AKT1 and melanoma: Yet, recent studies clearly show that adoptively transferred T cells treated ex vivo with a small molecule inhibitor of AKT, AKT inhibitor VIII (AKTi), exert stronger antitumor responses in both GVL and melanoma (9, 10).